Get the latest delivered to your inbox
Privacy Policy

Now Reading

Baxter Highlights Social, Economic and Environmental Performance in Seventh Annual Sustainability Report

Baxter Highlights Social, Economic and Environmental Performance in Seventh Annual Sustainability Report

Published 10-12-06

Submitted by Baxter International Inc.

DEERFIELD, Ill.- Baxter International Inc. (NYSE: BAX) announced today its social, economic and environmental performance in its 2005 Sustainability Report: 75 Years of Saving and Sustaining Lives. This report, which demonstrates the breadth and depth of Baxter's sustainability performance, commemorates the company's 75th anniversary of innovation and leadership in healthcare through historical photographs and company milestones.

Baxter's sustainability performance and leadership were recently recognized as the company was named 2006 Medical Products Industry Leader of both the Dow Jones Sustainability World Index (DJSI World) and the Dow Jones Sustainability North America Index (DJSI North America), the world's first benchmarks tracking the sustainability performance of top companies. Baxter's leadership position resulted from best scores across a number of performance areas, including bioethics, codes of conduct, environmental performance and policy/management, talent attraction and retention, and social and environmental reporting. 2006 marks the eighth consecutive year Baxter has been listed in the DJSI since its launch in 1999.

Baxter's 2005 Sustainability Report, available in print and online formats ( http://www.baxter.com/sustainability), is aligned with the Global Reporting Initiative guidelines and features in-depth reporting across key sustainability topics, including community support; corporate governance and business practices; employees; environment, health and safety; product responsibility and sustainability strategy. Additionally, for the first time, the report covers Baxter's economic impacts and the sustainability performance of the company's global supply chain. The report provides a balanced view of Baxter's programs and performance through extensive performance data, case studies and personal perspectives of external sustainability experts.

"At Baxter, we view sustainability as a long-term approach to balancing our business priorities with social, economic and environmental responsibilities, which aligns with the company's purpose to save and sustain people's lives," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "As our 47,000 employees celebrate Baxter's 75th anniversary of innovation and leadership in healthcare, we are pleased to present our most in-depth sustainability report to date."

Highlights from the 2005 report include:

  • Total 2005 environmental income, savings and cost avoidance of $85.8 million, up from $70.2 million in 2004;

  • New 2010 environmental, product stewardship, occupational health, safety and industrial hygiene goals;

  • Total giving by Baxter and The Baxter International Foundation exceeded $35 million, including product donations, cash contributions and foundation grants;

  • A discussion of Baxter's sustainability priority setting process and the formation of a cross-functional Sustainability Steering Committee;

  • Company disaster preparedness and response activities, including vaccine development and manufacture to protect against bio-terrorism and infectious diseases, including avian flu;

  • Baxter's participation in the Institute for Healthcare Improvement's 100,000 Lives Campaign, an initiative to save 100,000 lives in U.S. hospitals over 18 months through the adoption of best-safety practices; and

  • The launch of a new line of IV solution containers made of non-PVC (non-polyvinyl chloride) film, containing no latex and offering a DEHP-free [di (2-ethylhexyl) phthalate-free] fluid pathway to patients.

    About Baxter

    Baxter's longstanding commitment to sustainability spans nearly three decades, beginning with the establishment of a formal environmental program and policy in 1977. The company has been recognized by Innovest Strategic Value Advisors as one of the Global 100 Most Sustainable Corporations in the World. The company is a member of the Center for Corporate Citizenship at Boston College, the Business Environmental Leadership Council of the Pew Center on Global Climate Exchange, the Chicago Climate Exchange, the U.S. EPA's Climate Leaders, the Ethics & Compliance Officer Association and Hospitals for a Healthy Environment. Baxter endorses the Ceres principles and is an organizational stakeholder of the Global Reporting Initiative. Continual improvement of Baxter's sustainability programs and reporting depends in part on stakeholder feedback. Baxter welcomes comments through its online survey at www.baxter.com/input.

    Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

  • Baxter International Inc. logo

    Baxter International Inc.

    Baxter International Inc.

    At Baxter, sustainability means creating lasting social, environmental and economic value by addressing the needs of the company’s wide-ranging stakeholder base. The company's sustainability efforts support Baxter's mission to apply innovative science in the development of products and therapies that save and sustain patients' lives.

    More from Baxter International Inc.

    Join today and get the latest delivered to your inbox